Treat-to-target in psoriatic arthritis-cost-effective in the biosimilar era

Lancet Rheumatol. 2022 Jun;4(6):e390-e391. doi: 10.1016/S2665-9913(22)00101-1. Epub 2022 Apr 13.
No abstract available

Publication types

  • Letter